학술논문
The respiratory syncytial virus prefusion F protein vaccine attenuates the severity of respiratory syncytial virus-associated disease in breakthrough infections in adults ≥60 years of age
Document Type
Article
Author
Source
In: Influenza and other Respiratory Viruses . (Influenza and other Respiratory Viruses, February 2024, 18(2))
Subject
Language
English
ISSN
17502659
17502640
17502640